Tempus AI, Inc. (NASDAQ:TEM - Get Free Report) shares were up 3% on Thursday . The stock traded as high as $61.20 and last traded at $60.95. Approximately 3,059,627 shares were traded during trading, a decline of 58% from the average daily volume of 7,357,262 shares. The stock had previously closed at $59.18.
Wall Street Analyst Weigh In
A number of research firms recently weighed in on TEM. Piper Sandler upped their target price on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. Morgan Stanley upped their price target on shares of Tempus AI from $60.00 to $65.00 and gave the stock an "overweight" rating in a report on Friday, May 9th. Guggenheim boosted their target price on Tempus AI from $65.00 to $75.00 and gave the stock a "buy" rating in a research report on Monday. Needham & Company LLC restated a "buy" rating and issued a $70.00 target price on shares of Tempus AI in a research note on Wednesday, May 7th. Finally, BTIG Research assumed coverage on Tempus AI in a research report on Monday, April 21st. They set a "buy" rating and a $60.00 price target for the company. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $63.67.
Check Out Our Latest Research Report on TEM
Tempus AI Price Performance
The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. The company has a market cap of $10.50 billion and a PE ratio of -7.79. The firm's 50-day moving average is $62.23 and its 200-day moving average is $53.69.
Tempus AI (NASDAQ:TEM - Get Free Report) last announced its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The business had revenue of $255.74 million during the quarter, compared to the consensus estimate of $248.13 million. The company's quarterly revenue was up 75.4% compared to the same quarter last year. On average, equities analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current year.
Insider Buying and Selling
In other Tempus AI news, CAO Ryan M. Bartolucci sold 6,073 shares of the stock in a transaction that occurred on Tuesday, May 20th. The shares were sold at an average price of $63.23, for a total value of $383,995.79. Following the transaction, the chief accounting officer directly owned 47,799 shares in the company, valued at approximately $3,022,330.77. This trade represents a 11.27% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Erik Phelps sold 51,317 shares of Tempus AI stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52. Following the transaction, the executive vice president directly owned 97,779 shares in the company, valued at approximately $7,094,844.24. The trade was a 34.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 606,897 shares of company stock valued at $41,261,163 over the last ninety days. 27.60% of the stock is owned by insiders.
Hedge Funds Weigh In On Tempus AI
Institutional investors have recently added to or reduced their stakes in the company. Cherry Tree Wealth Management LLC purchased a new position in Tempus AI during the 1st quarter valued at $31,000. University of Texas Texas AM Investment Management Co. bought a new stake in shares of Tempus AI during the first quarter worth $33,000. Operose Advisors LLC purchased a new stake in shares of Tempus AI during the fourth quarter valued at $25,000. Bartlett & CO. Wealth Management LLC grew its holdings in shares of Tempus AI by 100.0% in the first quarter. Bartlett & CO. Wealth Management LLC now owns 800 shares of the company's stock worth $39,000 after purchasing an additional 400 shares during the last quarter. Finally, Nemes Rush Group LLC purchased a new position in Tempus AI in the 1st quarter worth about $39,000. Hedge funds and other institutional investors own 24.22% of the company's stock.
About Tempus AI
(
Get Free Report)
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Tempus AI, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.
While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
